RUNX1 and colorectal cancer: To evaluate the effect of RUNX1 in TGFβ1-mediated invasion in colorectal cancer cells, we conducted a wound-healing assay using three different colorectal cancer cell lines including HT29, SW620, or COLO320dm (Fig. 4d).